Author:
Lee Wonseok,Lee Sunghoon,Bae HyoungWon,Kim Chan Yun,Seong Gong Je
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference14 articles.
1. Kuwayama Y, Nomura A. Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety. Adv Ther. 2014;31(4):461–71.
2. Perez-Roca F, Rodrigo-Morales E, Garzon I, et al. Effects of four formulations of prostaglandin analogs on eye surface cells. A comparative study. PLoS One. 2015;10(6):e0129419.
3. Schnober D, Hubatsch DA, Scherzer ML. Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy. ClinOphthalmol. 2015;9:825–32.
4. Moon DRC, Ha SJ. Analysis of clinical effectiveness of tafluprost by ocular pulse amplitude. Korean J Ophthalmol. 2013;54(2):303.
5. Pinheiro R, Panfil C, Schrage N, Dutescu RM. The impact of glaucoma medications on corneal wound healing. J Glaucoma. 2016;25:122–7.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献